a viral vector vaccine uses a harmless live virus of a different kind as a carrier to transport genes from the dangerous virus. into cells in the recipient's body. a protein gene from the virus is 1st added to the benign one in the case of the novel coronavirus it's a spike protein gene. modified virus that resembles sars c.o.v. 2 in one key respect the immune system detects the offending protein and creates antibodies in response. for the safety requirements for growing the virus not as strict as with inactivated whole virus vaccines of. disadvantages are that it takes a lot of time and you have to choose vectors that are not affected by any preexisting immune response capability. and. then there are vaccines that use messenger or an egg for the novel coronavirus it is m r n a with instructions for making it spiked proteins. such vaccines prompt cells in the recipient to make such proteins themselves which in turn provoke an immune response although these proteins are not dangerous they are still identified enemies by the immune system which then creates antibodies and thus immunity.

astrazeneca's vaccine is a viral vector vaccine. what i've learned is the fda has asked for more research and data on previous studies of viral vector vaccines to try and see if there's any association between this adverse event and viral vector vaccine. this is important to assure safety, but most importantly, confidence during this turbulent race for a vaccine. >> when it comes to covid-19, researchers are warning the transmission risk is "rapidly increasing" across much of the northern u.s., from the pacific northwest to the midwest and northeast. what's to blame here? >> so it's very concerning, to be honest with you. as an emergency fith that has worked during the height of the pandemic in the middle of new york city, i fear that we're going to have a repeat of exponential growth. and for context, many public health officials are advising significant mitigation efforts for any area that exceeds 5%. states like wisconsin and south dakota are exceeding 20%. so these predictions are a warning from science that we must act now. >>

a viral vector vaccine uses a harmless live virus of a different kind as a carrier to transport genes from the dangerous virus. into cells in the recipient's body. a protein gene from the virus is 1st added to the benign one in the case of the novel coronavirus it's a spike protein gene. modified virus that resembles sars c.o.v. 2 in one key respect the immune system detects the offending protein and creates antibodies in response. to the safety requirements for growing the virus not as strict as within activated whole virus vaccines. disadvantages are that it takes a lot of time and you have to choose vectors that are not affected by any preexisting immune response capability. and. then there are a vaccine that use messenger or and they are the novel coronavirus it is m r n a with instructions for making it spiked proteins. such vaccines prompt cells in the recipient to make such proteins themselves which in turn provoke an immune response although these proteins are not dangerous they are still identified enemies by the immune system which then creates antibodies and thus immunity.

and we maintain this vector even today . we're looking at new technologies and new vectors new fields of science. i meet a lot of people a lot of specialists in our industry and lot of people in russia. when they think about the nuclear industry they think of it as a matter of pride of course there are always opponents but there are always people who don't like something though their number is minimal. we continue to work even with these people and i would like to emphasize that the majority of people view the russian nuclear industry as a kid vantage of russia it's a matter of national pride why nuclear energy over hydropower. no after it's what i thought were good then you would say well have you ever lived close to a hydroelectric power plant no. not yet i go on scott's actually i would love all year i grew up near the volga near to artificial lakes. when we create these artificial bodies of water you change the climate fundamentally and the consequences for the river is a drastic and quite negative a lot of artificial bo

what's that can you just explain what a vector is not heard this faxing sputnik vision human vector is another one g.'s monkey vectors can you just explain simply for everybody what that means yeah i can try so when i say lector it's the bike knowledge you. think you can to use the genetic make up for this next pick. the innate or the virus and use that to engineer a vaccine candidate on what i know to be playing a major role in that. region based on what science. understand to be. the truth one of the gin and the gene into unknown and then you. create or engineer the right into the. kind of the virus and that usually is believed to be much. less virulent than the actual fire that way when. i'm to develop the vaccine then this vaccine would go into our already and your response would trigger our immune system and then you will think that. the virus actually virus and thereby give the body. action when the actually. ok in a year no thank you very much for that and i also the question on everybody's lips haven't sat here and everybody else has a hug thinking well i can thinking about

tom: the differential on inflation vector, i don't think i have ever seen, where the u.s. is gently upward, higher inflation. there's just a rollover disinflation in europe. jonathan: that plays into the trade. now,ar in germany right -54 basis points. think about that. -54 basis points, in-line with

a viral vector vaccine uses a harmless live virus of a different kind as a carrier to transport genes from the dangerous virus. into cells in the recipient's body. a protein gene from the bad virus is 1st added to the benign one in the case of the novel coronavirus it's a spike protein gene. modified virus that resembles sars c.o.v. 2 in one key respect the immune system detects the offending protein and creates antibodies in response. for the safety requirements for growing the virus not as strict as within activated whole virus vaccines of. disadvantages are that it takes a lot of time and you have to choose vectors that are not affected by any preexisting immune response capability. and. then there are vaccines that use messenger or anay for the novel coronavirus it is m r n a with instructions for making it spiked proteins. such vaccines prompt cells in the recipient to make such proteins themselves which in turn provoke an immune response although these proteins are not dangerous they are still identified as enemies by the immune system which then creates antibodies and thus i me

disadvantages are that it takes a lot of time and you have to choose vectors that are not affected by any preexisting immune response capability. and. then there are vaccines that use messenger or an egg for the novel coronavirus it is m r n a with instructions for making it spiked proteins. such vaccines prompt cells in the recipient to make such proteins themselves which in turn provoke an immune response although these proteins are not dangerous they are still identified as enemies by the immune system which then creates antibodies and thus immunity. for. one advantage is that the safety requirements are much less stringent. another is that you can modify the r.n.a. quite quickly manufacturers say that within a short period of time perhaps 6 weeks are in a vaccines can be produced in very large volumes millions of units you can't match that with vector whole virus or other kinds of vaccine. leashed. so each of these approaches has upsides and downsides nonetheless they're all considered worth pursuing it is likely that we need more than one vaccine. i guess it grown i would just go

have pure souls together the crowd became one kind of fear of goodness that catapulted bitcoin on a vector that's escaping this place called planet earth and it's attracting. an intelligence and a spiritual force so powerful that not even this presidential election america is going to throw off last of course. so the bullish on him out of the bed because he's comparing the bitcoin space to the gold space and to the bond investor space to people shorting u.s. treasuries or shorting the dollar people betting against the u.s. economy by going long gold and he's basically i'm going to read you 2 quotes in tweets from him of people summarizing his appearance on c m b c in which he was even though he's a big old holder he's saying like that's a bet on dystopian future and that humanity is horrible and bitcoin is a bet that humans are are innovative and interesting and you know filled with life and possibility so p t j who is paul tudor jones said something incredible on c.m.t. see today quote i've never seen a store of value where you also have such great intellectual capital behind it when you

poder abrir el sobre y ver si el paciente estaba recibiendo el placebo ambas vacunas utilizan un vectorerpos >>> más allá de las vacunas compañías como (nombre en inglés) con sede en hialeah realizan ensayos clínicos sobre las actividades a base de anticuerpos >>> el anticuerpo actúa inmediatamente y se da una cobertura podríamos decir hasta tres o seis meses defendiendo según expertos médicos el caso de los ensayos clínicos de vacuna las suspensiones deberían de interpretarse como signo de confianza de que el proceso es transparente para garantizar la seguridad pública >>> la farmacéutica (nombre en inglés) incluir a personas jóvenes en su nueva fase de pruebas recientemente la empresa recibió aprobación de la fda para incluir a personas a partir de los 12 años de edad con ello, buscan saber los efectos que esta medicina pudiera tener en esas personaslas pruebas incluyen a individuos con algunas condiciones médicas crónicas como vih hepatitis b >>> en temas relacionados emprendió su trabajo durante la pandemia podría ser devastador para muchos, luis gonzález habló con un psicólogo que

the third vector i think is the most important, therapeutics and in many ways therapeutics are as or more important than a vaccine in the short and medium run. this is a way of driving down the mortality rate if you do get sick. these are things like remdesivir and monoclonal antibodies and convalescent plasma. 9 iy, i remember february wrote a memo to the task force. it said among other things, if we started a five company horse race on a vaccine development that week, we could have a vaccine by the end of november oror early december. we are actually tracking there. doctors do not understand how the trump administration work. doctors art -- about whether we can get large q quantities of the vaccine to the american people but what we have done is turn the standard paradigm on its head. usually you go sequentially. phase one, phase twophase three, you have got a vaccine then you start your investment in production capacity and it takes a year or two or more. that is not what we did. we did a simultaneous process where for all five of the vaccines we put in place mass production techn

can you give any kind of vector , a vector uptrade for u.s.ts, even a vector up for better imports? trade,ooking at world world trade is being held down by commodities, by things like energy products and materials and so forth. with our industrial structure, anywhere from 5% to 20% lower in terms of operation levels than where it was back in february, but we are seeing less trade and stuff that goes into the industrial machine, and that is dragging down world trade, particularly affecting emerging markets and the commodity producing countries that are largely the customers of things that we export from the united states. so this whole process is kind of a small bond process that starts with economic activity slowing in these fast countries which then refax out to the emerging world and reflects back into the united states to lower export sales. if we start with levels of industrial production going back to where we were before, we see the increase in commodities here that is the key thing. do not look at the growth rates. tell everyone to look

disadvantages are that it takes a lot of time and you have to choose vectors that are not affected by any preexisting immune response capability. and. then there are a vaccine that use messenger or anay for the novel coronavirus it is m r n a with instructions for making it spiked proteins. such vaccines prompt cells in the recipient to make such proteins themselves which in turn provoke an immune response although these proteins are not dangerous they are still identified as enemies by the immune system which then creates antibodies and thus i mean. one advantage is that the safety requirements are much less stringent. another is that you can modify the r.n.a. quite quickly manufacturers say that within a short period of time perhaps 6 weeks are in a vaccines can be produced in very large volumes millions of units you can't match that with vector whole virus or other kinds of vaccine stuff. so each of these approaches has upsides and downsides nonetheless they're all considered worth pursuing it is likely that we need more than one vaccine. i guess it's grown i would just go away lik

. >> this is from the vector institute based in siberia.nounced the new vaccine had been approved yesterday at a cabinet meeting, and it's also the case that just like with the first russian vaccine that was approved, the same is the case with the vector vaccine, that it has not gone through the key phase 3 trials which are the main trials to determine whether a vaccine is safe, and whether a vaccine is effective. those are the trials where the vaccine and placebo are given to tens of thousands of participants. the russians say with the vector vaccine, so far it's been administered to only about 100 people. 14 people in the phase one of the trial, and 86 people in phase 2 of the trial. however from what the scientists are saying, they say there are no serious side effects and they believe that the vaccine will be effective but again, of course those phase 2 trials have not started yet. they're saying they want to produce the vaccine to make about 60,000 doses as fast as possible. but one of the things that does appear to be clear is neither

of developments one of the key vectors of development of our country and my teachers those who taught me to manage this industry he always spoke about 2 key projects the soviet atom and the soviet space these were the 2 main project that helped our country to stay actively ahead of the curve and these were the drivers.

potentially capable of privilege bring almost a antigen to the need system and so there and they vector itself is designed to be known up look at ing sort of caught causing friction the capacity to do that the capacity to develop these vaccines has been in development for quite a long time but i recently has a really rich lawson shot under the pressure really you know developing a vaccine against of all of our us and that's been a success so that's good and we would like to see more of these vaccines going forward claiming a lot more experience with them and particularly around safety and around if you can see but there's no reason to suspect that they'll be problematic vaccines in fact they're likely to be very good vaccines where you have a range of potential at and of ours vectors some more frequently encountered by human populations than others then that differences of detention lead that could arise among the different products and that some of the that they tell it's coming out from some of the scientific literature but as a platform have you know it's a really exciting platform a

potentially capable of privilege bring almost a antigen to the need system and so there and they vector itself is designed to be known up look at ing sort of card causing friction the capacity to do that to get that city to develop these vaccines has been in development for quite a long time but i recently has a really rich lawson shot under the pressure really you know developing a vaccine against all of ours and that's been a success so that's good and we would like to see more of these vaccines going forward claiming a lot more experience with them particularly around safety and around if you can see but there's no reason to suspect that they'll be problematic vaccines in fact they're likely to be very good vaccines where you have a range of potential at and of ours vectors some more frequently encountered by human populations than others then that differences potentially that could arise among the different products and that some of the detail that's coming out from some of the scientific literature but as a platform have you know it's a really exciting platform and we hope that the

he is a vector of the disease. he is super spreading throughout the white house. he is doing a video. how dare he be optimistic? how did he look and what about the overall message? >> can i say the overall message, that's exactly what i learned about public health, what you're supposed to do. you are not supposed to so panic. you are supposed to reassure, give accurate information about risk. trust people to make good judgments on their own behalf. president did that i think tonight. don't you think? i think, obviously has a real spirit to him, doesn't he? i think that message is right. it is accurate. it's consistent with the data. covid is not a death sentence. i think we have created this idea in the public mind that it is something so unique and so deadly that we should utterly end all normal existence as a result of it. that's not right. we can have a much better way. protect the vulnerable. shield them for a short period of time until we reach a level where there's population immunity. and then for the rest of the world, let us live our lives. for folks who

potentially capable of privilege bring almost a antigen to the need system and so there and they vector itself is designed to be non-lethal accounting so it caught causing friction the capacity to do that the capacity to develop these vaccines has been in development for quite a long time but i recently has a really rich lawson shot under the pressure really you know developing a vaccine against of all of ours and that's been a success so that's good and we would like to see more of these vaccines going forward claiming a lot more experience with them particularly around safety and around if you can see but there's no reason to suspect that they'll be problematic accidents in fact they're largely to be very good vaccines where you have a range of potential at and of ours vectors some more frequently encountered by human populations than others then that differences of detention lead that could arise among the different products and that's some of the detail that's coming out from some of the scientific literature but as a platform have you know it's a really exciting platform and we hop

this has become a major vector of disease spread. >> more than half the u.s., 32 states, show upward trend in cases. yesterday, there were more than 71,000 new cases reported, the highest one day count since july. seven states saw the highest one day case totals, pennsylvania, indiana, ohio, oklahoma, utah, colorado, montana. seven states. the number of deaths increasing, the seven day average for deaths is 763. the highest it has been in a month. hospitalizations are soaring with more than 41,000 yesterday. that's 33% jump since beginning of october. and an influential model of the coronavirus pandemic predicts more than 385,000 deaths will occur in the u.s. by february 1st. that is a prediction. it doesn't have to be a fact. a new study projects more than 100,000 lives in the u.s. could be saved if we all wore masks. health reporter jacqueline howard has more on this. >> reporter: that's right, brianna. the new study finds if 95% of americans wear a mask in public, that could save lives. studies from institute for health metrics and evaluation, here's what the study found. in septe

how was he going to defend this and change the vector for the president?evin: i say this very simply because campaigns are essentially small businesses. so obviously, the ceo returning to work, but staffers at every level have contracted this virus. they are not immune to this virus, even though it is the office of. the executive, that has led to a from thelevel of angst lowest of low staffers to the upper echelons in terms of the inner circle of the president's closest advisors. all of that goes to show you what we are shaping up to have in salt lake city, which is a debate where you've got "the new york times" reporting that the debate commission is reportedly considering a virtual debate in miami next week, and a debate here in salt lake, where both of these vp nominees are just a heartbeat away from the presidency. jonathan: my old producer came up to be in london this morning and said if last week and the last debate was the fight, is tomorrow night the debate about policy? do you think we can focus on policy tomorrow? kevin: stylistically, you are ab

a viral vector a vaccine uses a harmless live virus something different kind as a carrier to transport genes from the dangerous virus. into cells in the recipient's body. a protein gene from the virus is 1st added to the benign one in the case of the novel coronavirus it's a spike protein gene. modified virus that resembles sars c.o.v. 2 in one key respect the immune system detects the offending protein and creates antibodies in response. for the safety requirements for growing the virus not as strict as with inactivated whole virus vaccines of the disadvantages are that it takes a lot of time and you have to choose vectors that are not affected by any preexisting immune response capability. and. then there are vaccines that use messenger or an egg for the novel coronavirus it is m r n a with instructions for making it spiked proteins. such vaccines prompt cells in the recipient to make such proteins themselves which in turn provoke an immune response although these proteins are not dangerous they are still identified as enemies by the immune system which then creates antibodies and th

this is a major vector of disease spread. >> the president had audience of millions. he could have said that. he didn't. >> no. he didn't. and frankly, secretary azar is talking about the public health strategies we've known for awhile, but these have not been implemented on a national scale. i mean, it makes a huge difference. we are the united states. people travel back and forth and areas that may have had better control, they were still effected by areas that had poorer control. that's the problem. now when you look at the map that you showed, the country is coalescing around a collective upward trend. before it was wave over here, wave over here, wave over here. now it is turning into a large surge. by the way, the other thing is what about testing. secretary azar talks about individual behavior and he is right. we just abandoned the idea of being able to test in a way that was meaningful. i can be with you onset now, despite that we don't have a vaccine if i can be tested regularly, you could be tested regularly, i would have confidence that i don't have it, i w

we have also learned that the vectors of this campaign and swing states are moving away from donald trumptoward him. right now, he is tied in texas. he is beginning to lose ground in kansas. he's still ahead in one of the most red states in the country. americans are exhausted by the incompetence of trump and the malfeasance of trump and they are looking at a different set of choices on november 3. i think it's very difficult to change the game at this point. >> clark, the handling of the people -- of the pandemic was a key part of the debate. do you think that biden aggressive action, they were talking about that she was talking about the dark winter, -- was talking about the dark winter. >> biden made a great start -- great statement when he said i want to shut down the virus, not shut down the country. donald trump is the president of the united states. what has happened in covid-19 in the pandemic ultimately his responsibility of donald trump. you cannot walk away from the fact that 220 million people have died. a thousand people are dying every single day. donald trump had to do two

. >> i don't want my little tour to become another news story and a vector for a virus. >> reporter: now back live, you're looking at the fourth floor where lisa's room supposedly was. a woman staying there told us she woke up to see a woman with pale skin, wearing a white dress and climbing up the curtain. that said the virtual ghost stories are said to be family friendly.>> a little ghost stor sure. >>> we've also posted a list of safer ways to celebrate halloween on our website. head to bay area.com. click the link at the top of the page and our trending bar. >>> still ahead a man is in a hospital after an explosion in a south bay home. plus. >> i'm going to tell him how hard it was. >> a change of heart after visiting her father in prison. we're introducing you to a young woman who is drawing on her personal experience to help other children across the state. >>> fire danger on the increase. i'll show you the focus of the gusty winds and. >>> a gilroy man has traumatic injuries from an explosion that happened yesterday. santa clara county sheriff bomb squad spent a day at the hou

the way a mosquito can be a vector, they take the blood and inject it into somebody else. right now, we don't have any evidence that covid is actually transmitted that way. in fact, when people look for covid or sars particles, you can't even find it. it's a mucousal in the mouth and lungs. really, that's where it's resonant. so the idea that mosquitos are transmitted, i would be very skeptical. i would keep my mind opened. >> beside, mosquito season is almost over. what about this one? we have been hearing about a new nasal spray that is supposed to produce the viral infective. what do you know about that? >> so are you talking about the air fabs? ucsf. so there is some really astute scientists and technically skilled to use these nanoparticles, really small nanoparticles as a way to prevent covid. it's currently being tested. i think they're working on some production that's used to then design trials, which i think would probably happen quickly, hopefully. and the idea is that is that would be an alternative for a vaccine and for people that can't get vaccinated for wha

the main in vector for covid righnow it is reckoned is young people.ng people aroften under the fects of alcohol, dropping their covid guard. restaurants and also expected to be hot -- to be told to shut, can stay open if they observe a maximum of six to a table and masks onllhe time except at the moment you are eating. young people are also targeted at universities, which have been told that lecture hls is now only be used at 50% capacity. some are skeptical about the bar closures, but resigned. >> i'm not surprised that my average age is the most uninhibited. people are still living like nothing is happening,at's why i don't think that closing the bars is going to make a difference. >> paris joinsil mars in what they call a state of massive covid alert. the next step would be a state of emergency. hugh schofield, bbc news, paris. katty: as we've reported on this progra some countries have handled this virus much better than others have. ny, noticeably, are in africa. one of the countries given a lot of international praise is senegal in west africa.

operation unfolding across social media, amplifying disinformation about voter fraud , and through other vectors to influence the selection, so russia denied interfering in the 2016 election, russia is denying interfering in the 2020 election. theia denied interfering in 1960 election when they were the soviet union and confronted by an administration official before the november election then. on the one hand, i would not pay too much heed to russia's denials, because they don't bear out by the facts, but on the messagend, it is a find to center there is no downside saying don't interfere in elections, and i wish the president would communicate that directly to the russian president, rather than say the threat does not exist or actually solicit help from russia, as he did before the 2016 election in asking for them to help find certain emails, so on the one hand, helpful message. on the other hand, let's be clear i didn't recognize russia is interfering in the 2020 election now. while mr. o'brien talking about whether russia seeks to manipulate vote tallies, as i said, electoral interference ca

berlin the court pointed out that it is not proven that restaurants and bars are one of the major vectors of spreading corona and that in fact there's another rule in place in regard to restaurants and bars that would serve the same purpose as the one that was overturned here namely bars and restaurants here are not allowed to serve alcohol after 11 pm and the court at least in this case viewed that as sufficient to ensure that people wouldn't relax their inhibitions and get too close to each other if the restaurant stayed open a little longer. i wonder whether you see a tendency or at threat there runs through these rulings. i absolutely do and it would be the attempt to balance justified the public goals of trying to ensure public health and safety against the constitution's protections of individual and commercial freedoms so in this case the court saying that the rules went too far in encroaching on businesses freedoms without enough of a clear public purpose for doing so. i should mention german health minister yen spawn finds the court's decision regrettable let's listen to what he

t so no reason to believe that the j & j product because it is also a virus vector vaccine would havets associated with it because it is a very different virus vehicle to are that they are using and they actually have a lot of experience with that virus using it as a vector for the delivery of vaccines. >> i thought about that. out of all the drugs i see, just advertised on "nightly news" every night, i want them all because they all sound great there is so much advertising not a single time do i remember monitoring the clinical trials of the drug that they are trying to sell me we're following this very closely and we never have. so let's go to adding remdesivir to the lilly antibody. are we convinced that the lildly a lilly and regeneron antibodies were safe and maybe it was the problem of the combination or are we not worried mabout the combination? >> one of the lilly trials was paused, the nih is conducting right now, hospitalized patients so there is a belief that there could be some side effect that became unmasked in that setting. the data that you led in with about remdesivir

potentially capable of privilege bring almost a antigen to the immune system and so there and they vector itself is designed to be known up look at ing sort of caught causing friction the capacity to do that the capacity to develop these vaccines has been in development for quite a long time but i recently has a really rich lawson shot and of the pressure really you know developing a vaccine against of all of ours and that's been a success so that's good and we would like to see more of these vaccines going forward claiming a lot more experience with them particularly around safety and around if you can see but there's no reason to suspect that they'll be problematic accidents in fact they're likely to be very good vaccines where you have a range of potential at and of our civic there's some more frequently encountered by human populations than others then at differences tension that could arise among the different products and that some of the that detail it's coming out from some of the scientific literature but as a platform have you know it's a really exciting platform and we hope tha

officially been registered school day at the back corona vaccine it's been developed by the siberia based vector state research center russian president vladimir putin made the announcement about it on wednesday. the vent to research center in the souvenirs is registered very cool in the 2nd russian vaccine against corona virus. now this new vaccine successfully passed phase $1.00 and $2.00 of clinical trials is now entering phase 3 with $40000.00 participants like the 1st the russian sputnik the vaccine it contains artificially synthesized fragments of the virus is also expected to provide long term immunity with more on this his aunties maria phenomena. phase $1.00 and $2.00 of its clinical trials and i'll be hind end here it was a success meaning the drug is safe now phase 3 is coming and it is a study in whether the vaccine is in fact effective we hear that around 40000 volunteers are expected to take part and for that purpose 60000 doses of the drug will be produced this is russian 2nd registered vaccine the 1st was registered back in august it is known as sputnik all satellite feed and we

registered in russia back in august it is known as sputnik all satellite feed it is and then the virus vector viral vaccine and we now hear from its developers that by november russia will be able to produce up to 6000000 doses of vaccine maining aid to may take up to 12 months to vaccinate around 80 percent of the country's population and as we hear from russia's president vladimir putin the russian citizens house is among the country's key priorities but. first we need to make these vaccines available on the russian markets they must be supplied to russian pharmacies on as large a scale as possible we continue to cooperate with our foreign partners and we will promote a vaccine abroad as well they're going to. international cooperation and foreign partners we know that 50 countries are already interested in russia's sputnik of the vaccine against kawiti we heard that from the head of russia's investment fund who just earlier this week came back from the united arab emirates where phase 3 of the clinical trials of sputnik was approved billeted to the sputnik. you know gold piece 3 was made i

has officially been registered the provoke corona vaccine has been developed by the siberia based vector state research center russia's president vladimir putin made this announcement on wednesday lucy just using. the vent to research center in the c.b.s. is registered a.p. vancouver on the 2nd russian vaccine against corona virus. well corona works like a composite sketch of a criminal suspect it contains antigens molecules that train the immune system to recognize the virus being synthesized artificially and so shouldn't pose much danger then when it comes to confronting the real virus the immune system should be ready the vaccine is expected to provide long term immunity to go over 90 with more here's me financially. phase $1.00 and $2.00 of its clinical trials and i'll be behind and here it was a success now phase 3 is coming and it is a study on whether the vaccine is in fact effective we hear that around 40000 volunteers are expected to take part and for that purpose 60000 doses of the drug will be produced this is russian 2nd registered vaccine the 1st was registered back in augus